PIMREG and pancreatic neoplasm: Univariate and multivariate Cox analyses confirmed the role of FAM64A expression as an independent risk factor for RFS in pancreatic cancer patients (HR = 2.5, 95%CI: 1.36–4.61, P = 0.003, Table 4).